Nu-Med Plus Presents at the 147th National Investment Banking Association Conference on November 12-13, 2019 in New York City SALT LAKE CITY, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), announced today that the Company attended and presented at the 147th National Investment Banking Association (NIBA)...

Nu-Med Plus, Inc. Announces Strategic Rebrand to Focus on Leading Advancements in the Nitric Oxide Delivery Industry SALT LAKE CITY, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, announces a new articulation of the...

Nu-Med Plus, Inc. announces Vice President of Medical Marketing discusses the exciting future of Nitric Oxide SALT LAKE CITY, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, announces that Dr. Brett Earl, Vice...

Nu-Med Plus, Inc. Approaches Landmark Certification to Speed New Nitric Oxide Medical Device Approval  SALT LAKE CITY, July 31, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB:NUMD), a medical device leader developing new nitric oxide delivery technology along with innovative applications in the...

Nu-Med Plus Shareholders Re-Elect All 5 Directors at 2018 Shareholder Meeting SALT LAKE CITY, April 24, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCBB:NUMD), a medical device development company, announced that on April 10, 2018, shareholders voted to re-elect all the...